Mentions
Extended reach
Total likes
Video views
AI synopsis
The social discussions emphasize the workshop's role in advancing mechanistic modeling for bioequivalence, with examples such as promotions for the virtual event and mentions of modeling techniques like PBPK, reflecting enthusiasm and recognition of its significance to regulatory science and industry practices.
Most posts show support or positive acknowledgment of the workshop and its significance for bioequivalence assessment.
The discussion demonstrates high intrigue about mechanistic modeling's role in regulatory science, indicated by calls to attend and promote the workshop.
Posts actively share details about the event, including registration info, and promote discussions about modeling approaches, reflecting a moderate but genuine level of engagement.
The posts suggest the workshop could influence future regulatory practices and industry understanding of bioequivalence, highlighting its potential importance.
Join the @US_FDA and @complexgenerics for a free virtual public workshop, "Regulatory Utility of Mechanistic Modeling to Support Alternative Bioequivalence Approaches" on September 30 - October 1, 2021. Advanced registration is required. https://t.co/riGY4Bm49d https://t.co/0S0xyR7oeX
Don't miss next week's @US_FDA, @complexgenerics virtual workshop "Regulatory Utility of Mechanistic Modeling to Support Alternative Bioequivalence Approaches." Email complexgenerics@rx.umaryland.edu with any questions, and RSVP to attend: https://t.co/AO2CTpc4ed https://t.co/NriW1iKnxm
Bioequivalence workshop reports: PBPK modeling for assessing food impact https://t.co/BIwVb82uIQ PBPK modeling to support alternative bioequivalence & risk assessment https://t.co/qrQIAOpVNd Mechanistic modeling to support alternative bioequivalence https://t.co/1hCDzqHKUx
RT @MCERSI: Join the @US_FDA and @complexgenerics for a free virtual public workshop, "Regulatory Utility of Mechanistic Modeling to Suppor…
The workshop aimed to help the generic drug industry and regulators understand how mechanistic modeling techniques, like physiologically based pharmacokinetic and fluid dynamics models, can improve bioequivalence…
RT @RosaQSP: Bioequivalence workshop reports: PBPK modeling for assessing food impact https://t.co/BIwVb82uIQ PBPK modeling to support alte…
Bioequivalence workshop reports: PBPK modeling for assessing food impact https://t.co/BIwVb82uIQ PBPK modeling to support alternative bioequivalence & risk assessment https://t.co/qrQIAOpVNd Mechanistic modeling to support alternative bioequivalence https://t.co/1hCDzqHKUx
Don't miss next week's @US_FDA, @complexgenerics virtual workshop "Regulatory Utility of Mechanistic Modeling to Support Alternative Bioequivalence Approaches." Email complexgenerics@rx.umaryland.edu with any questions, and RSVP to attend: https://t.co/AO2CTpc4ed https://t.co/NriW1iKnxm
RT @MCERSI: Join the @US_FDA and @complexgenerics for a free virtual public workshop, "Regulatory Utility of Mechanistic Modeling to Suppor…
Join the @US_FDA and @complexgenerics for a free virtual public workshop, "Regulatory Utility of Mechanistic Modeling to Support Alternative Bioequivalence Approaches" on September 30 - October 1, 2021. Advanced registration is required. https://t.co/riGY4Bm49d https://t.co/0S0xyR7oeX